KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Shares Outstanding (2016 - 2025)

AbbVie (ABBV) has disclosed Shares Outstanding for 13 consecutive years, with $1.8 billion as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding changed 0.17% to $1.8 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.8 billion, a 0.17% change, with the full-year FY2025 number at $1.8 billion, changed 0.17% from a year prior.
  • Shares Outstanding was $1.8 billion for Q4 2025 at AbbVie, roughly flat from $1.8 billion in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $1.8 billion in Q4 2022 to a low of $1.8 billion in Q1 2023.
  • A 5-year average of $1.8 billion and a median of $1.8 billion in 2021 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: increased 19.57% in 2021, then decreased 0.17% in 2023.
  • AbbVie's Shares Outstanding stood at $1.8 billion in 2021, then increased by 0.06% to $1.8 billion in 2022, then decreased by 0.17% to $1.8 billion in 2023, then decreased by 0.06% to $1.8 billion in 2024, then grew by 0.17% to $1.8 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Shares Outstanding are $1.8 billion (Q4 2025), $1.8 billion (Q3 2025), and $1.8 billion (Q2 2025).